Paul Kielholz
Paul Kielholz (15 November 1916 - 25 May 1990) was a Swiss psychiatrist, known mainly for his work on major depression, for example, for his method of overcoming antidepressant resistance by using simultaneous intravenous infusions of clomipramine and maprotiline, together with sulpiride and benzodiazepines.[1]
Biography
Paul Kielholz was born in 1916 in Switzerland.
Scientific works
![[icon]](/wiki/File:Wiki_letter_w_cropped.svg){kind=small} | This section is empty. You can help by adding to it. (August 2019) |
References
- ^ Kielholz, P; Terzani, S; Gastpar, M; Adams, C (22 May 1981). "Behandlung therapieresistenter Depressionen ohne Elektroschock" [Management of treatment-resistant depression without ECT (author's transl)]. Deutsche Medizinische Wochenschrift (in German). 106 (21): 671–673. doi:10.1055/s-2008-1070377. PMID 6113126.
| International | |
|---|---|
| National | |
| People | |
| Other | |
 | This biographical article about a scientist is a stub. You can help Wikipedia by expanding it. |